Z Squared (ZSQR) Research & Development (2022 - 2026)
Z Squared's Research & Development came in at $235,529 for Q1 2026, up 171.8% from $86,659 a year earlier but down 24.7% from the prior quarter.
Z Squared (ZSQR) Research & Development (2022 - 2026) Analysis & Trends
Over the trailing twelve months to Mar 31, 2026, Z Squared reported Research & Development of $1.43 million, down 13.1% year-over-year; for FY2025, it was $1.28 million, down 45.2% from FY2024.
- Research & Development carries a three-year compound annual growth rate of 294.0% (FY2022 to FY2025).
- Going back by year, Research & Development was $2.33 million in FY2024 (-65.0%), $6.67 million in FY2023 and $20,887 in FY2022.
- The five-year range for quarterly Research & Development is $20,887 (Q3 2022) to $5.07 million (Q3 2023).
- Year-over-year, Research & Development increased in 1 of the last eight quarters, with an average decline of 18.2%.
- The fastest year-over-year change in Research & Development over five years came in Q1 2024 (growth of 573.8%), and the weakest in Q1 2025 (a decline of 88.8%).
- Business Quant data shows ZSQR's Research & Development at $312,903 (Q4 2025), $587,279 (Q3 2025) and $290,309 (Q2 2025) in the three quarters before Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.98 Bn | 1,134.57 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 643.66 Bn | 563.53 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 500.95 Bn | 474.06 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 358.08 Bn | 312.45 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 301.84 Bn | 265.83 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 267.25 Bn | 240.94 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 241.42 Bn | 196.81 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 193.09 Bn | 167.28 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 171.63 Bn | 118.27 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Z Squared | 203.02 Mn | 176.25 Mn | -1.77 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 235,529.00 |
| Dec 31, 2025 | 312,903.00 |
| Sep 30, 2025 | 587,279.00 |
| Jun 30, 2025 | 290,309.00 |
| Mar 31, 2025 | 86,659.00 |
| Dec 31, 2024 | 343,878.00 |
| Sep 30, 2024 | 811,784.00 |
| Jun 30, 2024 | 398,817.00 |
| Mar 31, 2024 | 777,069.00 |
| Dec 31, 2023 | 1.01 Mn |
| Sep 30, 2023 | 5.07 Mn |
| Jun 30, 2023 | 466,629.00 |
| Mar 31, 2023 | 115,329.00 |
| Sep 30, 2022 | 20,887.00 |
Z Squared Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ZSQR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ZSQR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ZSQR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();